Developing minimal purification cryo-EM to understand mitochondrial myopathies

开发最小纯化冷冻电镜来了解线粒体肌病

• 批准号: 10732697
• 负责人: Gabriel C Lander
• 金额: $ 44.41万
• 依托单位: SCRIPPS RESEARCH INSTITUTE, THE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-01 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10732697
• 关键词: Affect; Biochemical; Biological Process; Cell physiology; Cells; Complex; Cryoelectron Microscopy; DNA Sequence Alteration; Data Collection; Defect; Development; Disease; Disease Progression; Drug Targeting; Drug resistance; Exercise; Functional disorder; Funding; Future; Genetic; Genetic Diseases; Human; Image; Individual; Investigation; Link; Macromolecular Complexes; Membrane Proteins; Metabolic; Methodology; Methods; Missense Mutation; Mitochondria; Mitochondrial Myopathies; Mitochondrial Proteins; Molecular; Mus; Muscle; Muscle Cells; Muscle Fibers; Muscle Mitochondria; Muscle function; Muscular Atrophy; Mutation; Myopathy; Neuromuscular Diseases; Organelles; Outcome; Oxidative Phosphorylation; Pathologic; Pathology; Patients; Production; Prokaryotic Cells; Protocols documentation; Relapse; Resolution; Sampling; Skeletal Muscle; Sorting; Structure; System; Technology; Therapeutic; Tissues; Visualization; Wasting Syndrome; Work; base; biological systems; cell type; data analysis pipeline; diagnostic tool; drug discovery; expectation; heterogenous data; insight; macromolecular assembly; mitochondrial dysfunction; particle; personalized medicine; protein function; protein purification; protein structure; proteostasis; structural biology

ABSTRACT Single particle cryoEM structure determination is now a widely used methodology that has revealed the detailed mechanisms underlying a wide range of biological systems. High-resolution single particle cryoEM studies have helped us understand how environmental or genetic factors perturb normal biological function, and how these factors can give rise to disease. Insights gained through such structural studies of cellular machinery have greatly benefited drug discovery efforts, as well as expanded our understanding of drug resistance and therapeutic relapse. However, successful single particle cryoEM structure determination continues to be dependent on the production and purification of highly homogeneous, biochemically stable samples for imaging. Here, we plan to harness the unique strengths of single particle cryoEM technologies - minimal sample requirements and an exceptional capacity for structural characterization of highly heterogeneous data - to move beyond this traditional approach. Precedence for such studies have been set by previous high-resolution cryoEM structures that were determined from heterogeneous mixtures of soluble or membrane-associated proteins extracted from single-cell lysates. We plan to extend these approaches to elucidate structures of endogenous mammalian mitochondrial complexes. In particular, the methodologies developed by this work will establish an avenue to perform structural investigation of mitochondrial complexes derived from mitochondrial myopathy patients. Mitochondrial dysfunction in skeletal muscle cells can have severe pathological outcomes, and is associated with a variety of muscle-wasting diseases and numerous neuromuscular disorders. One in 5000 individuals in the U.S. suffers from mitochondrial myopathies due to genetic mutation, and while substantial effort has been placed on understanding the genetics of these diseases, we lack an underlying molecular description of the specific perturbations responsible for pathology. Directly visualizing the endogenous mitochondrial complexes that carry mutations implicated in disease states enables us to inspect how missense mutations impact macromolecular assembly and interactions. We will develop mitochondrial isolation and structure determination methodologies to enable detailed structural assessment of the endogenous complexes involved in human mitochondrial proteostasis and the mitochondrial OXPHOS system, without the need for extensive protein purification. We have shown that mitochondrial lysates can be directly applied to EM grids and imaged to yield high-resolution structures of abundant complexes. We will further develop this pipeline to produce high-resolution structures of mitochondrial complexes and interaction partners from the distinct mitochondrial subcompartments, providing important molecular insights into how mutations associated with mitochondrial myopathies perturb protein structure and function. The results will advance our understanding of skeletal muscle myopathies through direct visualization of the machines involved in disease progression, unveiling never-before-seen mitochondrial assemblies, providing a molecular explanation for disease states, and laying the groundwork for future therapies.

抽象的 单个粒子冷冻结构确定现在是一种广泛使用的方法，已揭示了详细的方法 广泛的生物系统的基础机制。高分辨率的单粒子冷冻研究具有 帮助我们了解环境或遗传因素如何扰动正常的生物学功能，以及这些因素如何 因素可能引起疾病。通过这种细胞机械结构研究获得的见解极大 受益于药物发现工作，并扩大了我们对耐药性和治疗性的理解 复发。但是，成功的单粒子冷冻结构确定继续取决于 高度均匀的生化稳定样品的产生和纯化，用于成像。在这里，我们计划 利用单粒子冷冻技术的独特优势 - 最小样本要求和 高度异构数据的结构表征的出色能力 - 超越这种传统 方法。此类研究的优先事项是由以前的高分辨率冷冻结构确定的 由从单细胞提取的可溶性或膜相关蛋白的异质混合物确定 裂解物。我们计划将这些方法扩展到阐明内源性哺乳动物线粒体的结构 复合物。特别是，这项工作开发的方法将建立一条途径来执行结构 对线粒体肌病患者衍生的线粒体复合物的研究。线粒体 骨骼肌细胞功能障碍可能具有严重的病理结局，并且与多种 浪费肌肉疾病和许多神经肌肉疾病。美国5000人中有一个人受苦 由于基因突变引起的线粒体肌病 了解这些疾病的遗传学，我们缺乏对特定的基本分子描述 负责病理学的扰动。直接可视化携带的内源线粒体复合物 与疾病状态有关的突变使我们能够检查错义突变如何影响大分子 组装和互动。我们将开发线粒体隔离和结构测定方法 为了详细的结构评估，对人线粒体涉及的内源性复合物 蛋白质癌和线粒体的Oxphos系统，无需广泛的蛋白质纯化。我们 已经表明线粒体裂解液可以直接应用于EM网格并成像以产生高分辨率 丰富复合物的结构。我们将进一步开发该管道，以生成高分辨率结构 来自不同线粒体子组门的线粒体复合物和相互作用伙伴，提供 对线粒体肌病的突变如何扰动蛋白的重要分子见解 结构和功能。结果将通过直接提高我们对骨骼肌肌病的理解 可视化疾病进展的机器，从未见过的线粒体之前揭示 集会，为疾病状态提供分子解释，并为将来的疗法奠定基础。